iShares U.S. Pharmaceuticals ETF (IHE) Holdings $67.13 -0.23 (-0.34%) As of 07/18/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 40 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1JNJJohnson & Johnson$163.65+0.4%22.71%816,0972LLYEli Lilly and Company$771.78+1.3%21.84%156,6973RPRXRoyalty Pharma$35.59+0.3%4.82%744,2434VTRSViatris$8.88-4.2%4.71%2,821,9905PFEPfizer$24.46-0.5%4.69%1,035,1916MRKMerck & Co., Inc.$79.97-1.9%4.65%315,5067ZTSZoetis$148.61-0.9%4.33%152,3568BMYBristol Myers Squibb$47.40-1.4%4.30%505,2129ELANElanco Animal Health$14.78-1.2%3.62%1,374,42810JAZZJazz Pharmaceuticals$112.87-1.7%3.35%170,564 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11CORTCorcept Therapeutics$70.86-3.1%3.33%261,18912AXSMAxsome Therapeutics$111.70-0.5%2.13%114,45513PBHPrestige Consumer Healthcare$75.70+0.8%1.96%136,75214PRGOPerrigo$26.95-0.7%1.85%380,45515OGNOrganon & Co.$9.46-1.9%1.31%719,40416LGNDLigand Pharmaceuticals$139.10+1.1%1.09%53,39517SUPNSupernus Pharmaceuticals$32.34-3.7%0.89%154,94718TARSTarsus Pharmaceuticals$43.25+4.5%0.77%105,80519AMRXAmneal Pharmaceuticals$7.97-3.3%0.62%416,28720HRMYHarmony Biosciences$35.20-3.4%0.61%106,47321OCULOcular Therapeutix$11.33-0.4%0.60%357,08722ANIPANI Pharmaceuticals$66.30-2.6%0.55%47,07823INVAInnoviva$19.57-1.6%0.53%152,85324PCRXPacira BioSciences$21.59-3.1%0.53%128,12325COLLCollegium Pharmaceutical$31.20-3.3%0.49%88,90826HROWHarrow$35.89-0.7%0.48%87,31127EWTXEdgewise Therapeutics$13.54-1.4%0.45%192,04128AMPHAmphastar Pharmaceuticals$20.62-5.0%0.43%101,68629ELVNEnliven Therapeutics$22.66-2.9%0.40%108,28130WVEWAVE Life Sciences$8.34+4.1%0.40%328,18831LQDALiquidia Technologies$14.54-0.4%0.29%132,27532ARVNArvinas$7.35-5.3%0.27%188,16833NUVBNuvation Bio$2.31+3.1%0.26%714,68334MNMDMind Medicine (MindMed)$8.880.24%188,47735EOLSEvolus$9.20-1.5%0.23%139,40336TBPHTheravance Biopharma$11.25-3.2%0.19%98,37137BLK CSH FND TREASURY SL AGENCYN/A0.08%441,58438CASH COLLATERAL USD SGAFTN/A0.01%37,00039USDProShares Ultra Semiconductors$83.21-0.9%0.01%59,51440E-MINI HEALTH CARE SECTOR SEP 25N/A0.00%3Missed the Run So Far? This Is Your Second Chance (Ad)According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up. Join The Crypto Code Workshop + get $10 in Bitcoin for attending Geographic ExposureUnited States94.0%Ireland5.3%Singapore0.5%Cayman Islands0.2%Currency ExposureUSD100.0%Sector ExposureHealth Care99.3%Energy0.5%Industry ExposureBiotechnology80.7%Pharmaceuticals17.9%Health Care Equipment & Supplies0.7%Renewable Energy0.5%SubIndustry ExposureBiotechnology76.5%Pharmaceuticals20.4%Health Care Supplies0.7%Renewable Energy Equipment0.5%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies VanEck Pharmaceutical ETF Portfolio iShares U.S. Healthcare Providers ETF Portfolio Direxion Daily S&P Biotech Bull 3x Shares Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio VanEck Biotech ETF Portfolio Invesco Pharmaceuticals ETF Portfolio First Trust Health Care AlphaDEX Fund Portfolio Invesco Biotechnology & Genome ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio SPDR S&P Pharmaceuticals ETF Portfolio This page (NYSEARCA:IHE) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.